Lonza expands EU production capacity for M...Lonza will expand its production capacity of Modernas mRNA vaccine mRNA1273 at its manufacturing site in Geelen, the Netherlands. more ➔
EU approves Biontech/Pfizer vaccine for ad...The European Medicines Agency (EMA) has given the green light for vaccination of adolescents with Biontech’s COVID-19 vaccine Comirnaty (BNT162b2). more ➔
Senti Bio and Bluerock ink Regmed collabor...Senti Biosciences and Bayer subsidiary BlueRock Therapeutics form strategic partnership to combine iPSC and gene circuit-engineered cell therapy platforms. more ➔
Pieris in $1.4bn deal with RocheGerman-US Anticalin specialist Pieris Pharmaceuticals has bagged $20m upfront for a strategic R&D and license agreement with Genentech, the US branch of Swiss Roche AG. more ➔
Associations call for acceleration of ATMP...Life science associations are calling for ATMPs to be exempted from the strict EU GMO rules, as their different legal interpretations in EU member states are delaying applications for multicentre clinical … more ➔
COVID-19 med APN01 selected to be tested i...APEIRON Biologics recombinant ACE2 APN01 has been selected to participate in the US ACTIV study. ACTIV is aimed to speed up development of the best COVID-19 meds. more ➔
Hummingbird Bioscience raises $125m in Ser...Danish Novo Holdings A/S has led an oversubscribed US$125m Series C into the cancer antibody specialist Hummingbird Bioscience. more ➔
BD installs production hub in ZaraogzaBD will build a €165m manufacturing facility in Zaragoza, Spain to support the growth of its pre-filled drug delivery business. more ➔
COVID-19 therapeutics: Germany launches ...German government has launched a €300m programme designed to bring clinically tested COVID-19 treatments to the patient’s bedside. more ➔
Recombinant silk producer AMSilk raises ...AMSilk GmbH has closed a Series C financing at €29m to accelerate and expand commercialisation of its microbially produced silk fibres. more ➔
